Search results
Gaston 6-year-old to have the summer of her life while fighting cancer
The Gaston Gazette via Yahoo News· 1 day agoA Gaston family is seeking solace in the community as six-year-old Harmony Nicholson’s months-long...
12-year-old beats rare brain cancer but after 3 years remission is now battling a new form of brain...
WZZM 13 Grand Rapids· 2 days agoNearly six years ago, now 12-year-old Emerson Hoogendoorn was diagnosed with diffuse midline glioma,...
Gene therapy offers huge potential for combating disease, doctors say
United Press International via Yahoo News· 6 days agoResearchers are engineering ways to alter genes or swap flawed ones with healthy replacements,...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoIN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies, presented encouraging preliminary clinical data of INB-200 at ...
New research platform assesses brain cancer mutations during surgery
Medical Xpress· 7 days agoBrain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published in Proceedings ...
June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge
InvestorPlace· 1 day agoBiotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the...
Community supports 12-year-old cancer patient who ‘beat the unbeatable’
WOOD via Yahoo News· 3 days agoEmerson Hoogendoorn's loved ones say she can be described in many words: kind, strong, giving. But...
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that transfusion-dependent thalassemia patients who received...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of
Researchers create 'chameleon' compound that targets drug-resistant brain cancers
Medical Xpress· 3 days agoThe research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target an array of pernicious ...